Clinical Trial Update: Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating outpatient administration of Teclistamab or Talquetamab in patients with multiple myeloma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Talquetamab (talquetamab)
• Tecvayli (teclistamab) (teclistamab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Multiple Myeloma | Phase 2 | Status: RECRUITING